Non-CME/CE
Infectious Diseases
Learn about clinical trial data and real-world evidence behind an oral treatment option for adults with COVID-19 at high risk for progression to severe illness. Additionally, we will discuss how to identify high-risk patients, tools and resources to manage potential DDIs, and more.
Pfizer, Inc.